Page 4 - Clinical Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synairgen plc: COVID-19 Clinical Programme Update Phase III trial design adapted which will expedite results Phase III trial to commence dosing in UK imminently Southampton, UK - 18 December 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces updates to the Company's Phase III trial design evaluating SNG001 as a treatment for patients with COVID-19 and positive progress on the regulatory path. Update to Phase III trial (SG018) protocol in COVID-19 patients Following discussions with the regulatory agencies, the trial has been amended as f...

Vacancy for position of Psychosocial Professional 18 Dec 2020 This story is sponsored The Centre for the Study of Violence and Reconciliation (CSVR) is a nongovernmental organisation, which envisions societies that are peaceful, equal and free from violence. CSVR aims to understand and prevent violence, heal its effects and build sustainable peace at community, national and regional levels. We do this through collaboration with and learning from the lived and diverse experiences of communities affected by violence and conflict to inform innovative interventions, generate knowledge, shape publ...